Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey

被引:49
|
作者
Dorman, Susan E. [1 ]
Chihota, Violet N. [2 ]
Lewis, James J. [2 ,3 ]
Shah, Maunank [1 ]
Clark, David [2 ]
Grant, Alison D. [3 ]
Churchyard, Gavin J. [2 ,3 ,4 ]
Fielding, Katherine L. [3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
[2] Aurum Inst Hlth Res, Johannesburg, South Africa
[3] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England
[4] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa
来源
PLOS ONE | 2012年 / 7卷 / 08期
基金
美国国家卫生研究院;
关键词
MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; RIFAMPIN RESISTANCE; RANDOMIZED-TRIAL; DIAGNOSIS; HIV; ASSAY; ERA;
D O I
10.1371/journal.pone.0043307
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Xpert MTB/RIF ("Xpert'') is a molecular test for detection of Mycobacterium tuberculosis (MTB) in sputum. Performance characteristics have been established for its use during passive tuberculosis (TB) case detection in symptomatic TB suspects, but Xpert performance has not been assessed in other settings. Objectives were to determine Xpert performance and costs in the context of a TB prevalence survey. Methodology/Principal Findings: This was a diagnostic sub-study of a TB prevalence survey conducted in gold mining companies in South Africa. Sputa (one per participant) were tested using smear microscopy, liquid culture (reference comparator), and Xpert. Costs were collected using an ingredients approach and analyzed using a public health program perspective. 6893 participants provided a sputum specimen. 187/6893 (2.7%) were positive for MTB in culture, 144/6893 (2.1%) were positive for MTB by Xpert, and 91/6893 (1.3%) were positive for acid fast bacilli by microsocopy. Sensitivity, specificity, positive predictive value, and negative predictive value for detection of MTB by Xpert were 62.6% (95% confidence interval [CI] 55.2, 69.5), 99.6% (99.4, 99.7), 81.3% (73.9, 87.3), and 98.9 (98.6, 98.8); agreement between Xpert and culture was 98.5% (98.2, 98.8). Sensitivity of microscopy was 17.6% (12.5, 23.9). When individuals with a history of TB treatment were excluded from the analysis, Xpert specificity was 99.8 (99.7, 99.9) and PPV was 90.6 (83.3, 95.4) for detection of MTB. For the testing scenario of 7000 specimens with 2.7% of specimens culture positive for MTB, costs were $165,690 for Xpert and $115,360 for the package of microscopy plus culture. Conclusion: In the context of a TB prevalence survey, the Xpert diagnostic yield was substantially higher than that of microscopy yet lower than that of liquid culture. Xpert may be useful as a sole test for TB case detection in prevalence surveys, particularly in settings lacking capacity for liquid culture.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Performance of Xpert MTB/RIF on pleural tissue for the diagnosis of pleural tuberculosis
    Christopher, Devasahayam J.
    Schumacher, Samuel G.
    Michael, Joy S.
    Luo, Robert
    Balamugesh, Thangakunam
    Duraikannan, Paramasivan
    Pollock, Nira R.
    Pai, Madhukar
    Denkinger, Claudia M.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (05) : 1427 - 1429
  • [22] Impact of the Xpert® MTB/RIF molecular test on the late diagnosis of pulmonary tuberculosis
    Buchelli Ramirez, H. L.
    Garcia-Clemente, M. M.
    Alvarez-Alvarez, C.
    Palacio-Gutierrez, J. J.
    Pando-Sandoval, A.
    Gagatek, S.
    Arias-Guillen, M.
    Quezada-Loaiza, C. A.
    Casan-Clara, P.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (04) : 435 - 437
  • [23] STUDYING THE EFFECTIVENESS OF XPERT MTB/RIF TEST IN PATIENTS SUSPECTED WITH PULMONARY TUBERCULOSIS
    Hang Le Minh
    Viet Anh Trinh
    Giap Vu Van
    Hanh Chu Thi
    Phuong Phan Thu
    Chau Ngo Quy
    Hang Le Minh
    RESPIROLOGY, 2015, 20 : 155 - 155
  • [24] Incremental Yield of Xpert MTB/RIF Ultra over Xpert MTB/RIF in the diagnosis of extra-pulmonary tuberculosis
    Christopher, Devasahayam Jesudas
    Shankar, Deepa
    Victor, Coelho
    Simon, Ebby
    Thangakunam, Balamugesh
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [25] Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays
    Murray, Patrick
    Cooper, Charles
    Maus, Courtney
    JOURNAL OF CLINICAL MICROBIOLOGY, 2019, 57 (09)
  • [26] Characteristics of Xpert MTB/RIF-Negative Patients With Pulmonary Tuberculosis Reply
    Lawn, Stephen D.
    Kerkhoff, Andrew D.
    Wood, Robin
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (03) : 473 - U197
  • [27] Xpert® MTB/RIF in pleural fluid for the diagnosis of tuberculosis
    Porcel, J. M.
    Palma, R.
    Valdes, L.
    Bielsa, S.
    San-Jose, E.
    Esquerda, A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (09) : 1217 - 1219
  • [28] Xpert MTB/RIF: monitoring response to tuberculosis treatment
    Nicol, Mark P.
    LANCET RESPIRATORY MEDICINE, 2013, 1 (06): : 427 - 428
  • [29] Clinical Characteristics of Pulmonary Tuberculosis in Children Tested by Xpert MTB/RIF Ultra
    Quan, Shuting
    Zou, Tingting
    Duan, Li
    Tian, Xue
    Wang, Yacui
    Zhu, Yu
    Fang, Min
    Shi, Yan
    Wan, Chaomin
    Sun, Lin
    Shen, Adong
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (05) : 389 - 395
  • [30] Urine Xpert MTB/RIF for the diagnosis of childhood tuberculosis
    Lopez, Anna Lena
    Aldaba, Josephine G.
    Morales-Dizon, Merrylle
    Sarol, Jesus N.
    Daag, Jedas Veronica
    Ama, Ma Cecilia
    Sylim, Patrick
    Salonga, Aida
    Nielsen-Saines, Karin
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 79 : 44 - 46